Archives for December 5, 2017

← 2017

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.